243 related articles for article (PubMed ID: 15507543)
1. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism.
Rodriguez M; Nemeth E; Martin D
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F253-64. PubMed ID: 15507543
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
McCann LM; Beto J
J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
[TBL] [Abstract][Full Text] [Related]
5. [Basic and clinical aspects of calcimimetics. The pathogesis and treatment of secondary hyperparathyroidism].
Mizobuchi M; Akizawa T
Clin Calcium; 2008 Jan; 18(1):13-9. PubMed ID: 18175866
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Ito H; Kinugasa E
Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
[TBL] [Abstract][Full Text] [Related]
7. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
Carrillo-López N; Fernández-Martín JL; Cannata-Andía JB
Nefrologia; 2009; 29(2):103-8. PubMed ID: 19396314
[TBL] [Abstract][Full Text] [Related]
8. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Gene therapy for secondary hyperparathyroidism].
Kanai G; Fukagawa M
Clin Calcium; 2010 Jul; 20(7):1052-9. PubMed ID: 20585184
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
Caudrillier A; Mentaverri R; Brazier M; Kamel S; Massy ZA
J Nephrol; 2010; 23(1):17-22. PubMed ID: 20091482
[TBL] [Abstract][Full Text] [Related]
10. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
Cunningham J; Locatelli F; Rodriguez M
Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease.
Torres PA; De Broe M
Kidney Int; 2012 Jul; 82(1):19-25. PubMed ID: 22437409
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
13. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Sprague SM; Coyne D
Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
15. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
Cozzolino M; Brancaccio D
Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
[TBL] [Abstract][Full Text] [Related]
16. The need for better control of secondary hyperparathyroidism.
Locatelli F
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V15-19. PubMed ID: 15284355
[TBL] [Abstract][Full Text] [Related]
17. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
Fernández Martín JL; González Suárez I; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
[TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
Cañadillas S; Canalejo A; Santamaría R; Rodríguez ME; Estepa JC; Martín-Malo A; Bravo J; Ramos B; Aguilera-Tejero E; Rodríguez M; Almadén Y
J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
[TBL] [Abstract][Full Text] [Related]
19. [The challenge of hyperphosphatemia control in chronic kidney disease].
Lorenzo Sellares V
Nefrologia; 2008; 28 Suppl 5():3-6. PubMed ID: 18847412
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
Cozzolino M; Ciceri P; Volpi EM; Olivi L; Messa PG
Blood Purif; 2009; 27(4):338-44. PubMed ID: 19295196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
